Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group.

Ganzetti G, Campanati A, Bettacchi A, Brandozzi G, Brisigotti V, Bugatti L, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.

G Ital Dermatol Venereol. 2018 Feb;153(1):5-10. doi: 10.23736/S0392-0488.16.05463-8. Epub 2016 Nov 15.

PMID:
27845513
2.

The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region.

Ganzetti G, Campanati A, Bernardini ML, Bettacchi A, Brandozzi G, Brisigotti V, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.

G Ital Dermatol Venereol. 2016 Aug;151(4):340-6. Epub 2015 Jun 19.

PMID:
26091276
3.

Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation.

Arcese A, Aste N, Bettacchi A, Camplone G, Cantoresi F, Caproni M, D'Amico D, Fabbri P, Filosa G, Galluccio A, Hansel K, Lisi P, Micali G, Musumeci ML, Nicolini M, Parodi A, Patania M, Pezza M, Potenza C, Richetta A, Simonacci M, Trevisan P, Valenti G, Calvieri S.

Clin Drug Investig. 2010;30(8):507-16. doi: 10.2165/11537470-000000000-00000.

PMID:
20586516
4.

Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.

Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Bettacchi A, Mulattieri S, Picardi P, Tassetti A, Scortechini AR, Fioritoni G, Leoni P.

Eur J Haematol. 2009 Mar;82(3):184-93. doi: 10.1111/j.1600-0609.2008.01197.x.

PMID:
19215609
5.

Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.

Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Tassetti A, Scortechini AR, Offidani M, Mulattieri S, Stronati A, Brandozzi G, Giacchetti A, Mozzicafreddo G, Ricotti G, Filosa G, Bettacchi A, Simonacci M, Novelli N, Leoni P.

Haematologica. 2007 May;92(5):686-9.

6.

Relationship between cause of referral and diagnostic outcome in pigmented lesion clinics: a multicentre survey of the Italian Multidisciplinary Group on Melanoma (GIPMe).

Carli P, De Giorgi V, Betti R, Vergani R, Catricala C, Mariani G, Simonacci M, Bettacchi A, Bottoni U, Lo Scocco G, Mulas P, Giannotti B.

Melanoma Res. 2003 Apr;13(2):207-11.

PMID:
12690308
7.

Nodular secondary syphilis.

Papini M, Bettacchi A, Guiducci A.

Br J Dermatol. 1998 Apr;138(4):704-5.

PMID:
9640385
8.

Violence against women: provider barriers to intervention in emergency departments.

McGrath ME, Bettacchi A, Duffy SJ, Peipert JF, Becker BM, St Angelo L.

Acad Emerg Med. 1997 Apr;4(4):297-300.

9.

Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon.

Papini M, Bruni PL, Bettacchi A, Liberati F.

Int J Dermatol. 1994 Mar;33(3):221-2. No abstract available.

PMID:
8169033

Supplemental Content

Loading ...
Support Center